Regression-based convolutional neural network that directly estimates the heart-rate-corrected QT interval (QTc) from a 12-lead ECG, aiming to improve on automated QTc measurements from commercial ECG systems, which often diverge from expert readings. QTcNet was trained on 120,300 algorithm-labeled ECGs from an internal hospital cohort and the public MIMIC-IV database (after correcting for a vendor-specific measurement bias), and evaluated against expert QTc measurements in three independent external cohorts (PTB Diagnostic ECG Database, QTcMS, and ECGRDVQ). It roughly halved the mean absolute error compared with standard ECG analysis software (from 23.4ms to 13.4ms across external validation cohorts), with explainability analysis confirming the model focuses on physiologically plausible QRS-onset and T-offset regions.

Multi-label 12-lead ECG diagnosis model submitted to the PhysioNet/Computing in Cardiology Challenge 2020, built on the same residual 1D CNN family as the authors' earlier Nature Communications model but retrained and validated across the challenge's large, multi-institutional pooled training set (CPSC2018, China 12-Lead ECG Database, St. Petersburg INCART, PTB and PTB-XL, and the Georgia 12-Lead ECG Database). The model uses an unsupervised pretraining stage -- predicting unseen samples of a partially masked ECG signal -- before supervised fine-tuning to jointly detect nine diagnostic classes (atrial fibrillation, first-degree AV block, left and right bundle branch block, normal rhythm, premature atrial/ventricular contraction, and ST-segment depression/elevation). The 2020 Challenge was notable for requiring every team to publicly release both their trained model weights and full training code, making this one of relatively few 12-lead ECG classifiers with an end-to-end reproducible public pipeline.

Multimodal deep-learning framework that estimates and forecasts abnormal laboratory values directly from a 12-lead ECG plus routinely available demographics, biometrics, and vital signs -- reframing dozens of blood tests as binary classification targets predictable from a test that is already fast, non-invasive, and nearly universal in acute care. A structured state-space (S4) encoder processes the raw ECG waveform and is late-fused with an MLP encoder over the tabular metadata; the same architecture is trained both to estimate the closest lab value within 60 minutes of the ECG ('abnormality prediction') and to forecast whether a value will become abnormal 30/60/120 minutes into the future ('abnormality forecasting'). Trained and evaluated on 385,480 linked ECG-lab-value samples from 127,994 MIMIC-IV patients, the model reaches AUROC > 0.7 for 24 distinct lab abnormalities in the prediction setting and 24 in the forecasting setting, spanning cardiac, renal, hematological, metabolic, immunological, and coagulation categories -- with NT-proBNP elevation the best-predicted marker (AUROC 0.90), followed by hemoglobin, albumin, and hematocrit derangements (AUROC > 0.82). Code for dataset construction, training, and evaluation is public under an MIT license; no pretrained model weights are released.

Supervised EfficientNetV2-based 12-lead ECG model trained on over 1 million ECGs from the Montreal Heart Institute to predict 77 cardiac conditions derived from American Heart Association recommendations, plus fine-tuned digital-biomarker heads for reduced LVEF, 5-year atrial-fibrillation risk, and long-QT-syndrome (LQTS) detection/genotyping. Validated on 881,403 ECGs across 11 geographically diverse cohorts (4 public, 7 private health systems), achieving AUROCs above 0.98 for the 77-condition interpretation task while being 60x smaller and 29x faster at inference than its self-supervised DeepECG-SSL counterpart, with up to 9.7x lower CO2 emissions on equivalent tasks.

Self-supervised EfficientNetV2-based 12-lead ECG foundation model pretrained via contrastive learning and masked-lead modeling on 1.9 million ECGs (Montreal Heart Institute plus CODE-15% and MIMIC-IV), then fine-tuned for the same 77-condition ECG interpretation task and digital-biomarker extraction as DeepECG-SL. Outperforms the supervised counterpart on label-scarce digital-biomarker tasks, with the largest gains on LQTS genotype classification (AUROC 0.931 vs. 0.850, n=127 ECGs) and 5-year atrial-fibrillation risk (AUROC 0.742 vs. 0.734, n=132,050 ECGs), and outperforms ECG-FM and ECGFounder on shared external diagnostic classes.

ECG foundation model designed to remain accurate when leads are missing or signals are noisy. A 1D ConvNeXt V2 encoder is trained with a dual-mode self-distillation objective (separate lead-missing and noise "teachers") alongside contrastive alignment to detailed diagnostic-criteria text reports retrieved via a lightweight, LLM-free "Cardiac Feature Retrieval" module. Consistently ranks best or second-best across PTB-XL diagnostic tasks and MIT-BIH arrhythmia classification under original, noisy, lead-missing, and combined-corruption conditions. Developed by FPT Software AI Center and the University of Arkansas.

CNN-based image classifier that screens 12-lead ECG images for a signature of transthyretin amyloid cardiomyopathy (ATTR-CM), producing a study-level probability score. Trained on a private Yale New Haven Health System cohort of nuclear-imaging-confirmed ATTR-CM cases and matched controls. Used alongside a companion echocardiography model to track pre-clinical ATTR-CM progression years before it would otherwise be confirmed by nuclear amyloid imaging. Developed by Yale's CarDS Lab and distributed as a packaged research-use executable rather than downloadable weights.

EfficientNet-B3 CNN that detects hypertrophic cardiomyopathy directly from images of printed or scanned 12-lead ECGs, rather than from raw digital waveforms, enabling screening from a photo of a paper tracing. Initialized via self-supervised contrastive pretraining on patient identity, then fine-tuned at Yale New Haven Hospital on over 124,000 ECGs from about 67,000 patients, with HCM status confirmed by cardiac MRI or echocardiography. Externally validated on ECG images from MIMIC-IV, Amsterdam UMC, and UK Biobank. Developed by Yale's CarDS Lab.

Screens 12-lead ECGs for Chagas cardiomyopathy by first pretraining a feature extractor to predict blood-biomarker levels from MIMIC-IV-ECG data, then fine-tuning on Brazilian CODE-15%, SaMi-Trop, and PTB-XL recordings; the final model is a 5-model ensemble. Submitted to the George B. Moody PhysioNet Challenge 2025 (Detection of Chagas Disease from the ECG), where it placed 5th on the official leaderboard. Developed by a team from Akershus University Hospital and the University of Oslo.

Reconstructs digital 12-lead ECG waveforms from scanned or photographed paper printouts, using an nnU-Net image segmentation model to trace the signal pixels followed by a Hough-transform-based reconstruction pipeline. This is a digitization tool rather than a diagnostic model - it recovers a usable signal from a paper record rather than producing a diagnosis. Won the PhysioNet/Computing in Cardiology Challenge 2024; developed by a team at the University of Oxford.

1D residual neural network that predicts a patient's age directly from a 12-lead ECG; the gap between this predicted 'ECG age' and true chronological age is used as a biomarker of cardiovascular risk and mortality. Trained on the CODE-15% Brazilian ECG dataset, with the original R² of 0.71 later reproduced (R² = 0.70) in an independent German validation cohort. Developed by researchers at Uppsala University and UFMG.

Large-scale ECG foundation model pretrained on more than 10 million recordings spanning 150 label categories from the Harvard-Emory ECG Database. Built as a general-purpose feature extractor that can be fine-tuned for arrhythmia detection, demographic inference, and event prediction, and externally validated on MIMIC-IV-ECG and PTB-XL. Also used as the pretrained backbone for downstream clinical models such as Pocket-K, a hyperkalemia detector. Developed by Peking University and Harvard-Emory researchers.

Reference benchmark suite for the PTB-XL ECG dataset, providing pretrained xresnet1d, InceptionTime, LSTM, and CPC-pretrained models for 71-label, diagnostic, sub-diagnostic, and super-diagnostic classification of ECG findings. Widely used as a standardized baseline for comparing new ECG classification methods. Developed by Strodthoff et al. at Fraunhofer HHI.

Generative adversarial network that synthesizes realistic 10-second, 12-lead normal-sinus-rhythm ECGs from scratch, without using any real patient data at inference time, enabling privacy-preserving data sharing and augmentation. Uses a U-Net-style 1D deconvolutional generator with a WaveGAN-inspired discriminator. Outperformed a WaveGAN* baseline on the fraction of generated tracings classified as normal sinus rhythm by a commercial ECG interpretation algorithm. Developed by SimulaMet and Oslo Metropolitan University.